Related Experiment Videos
A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation
M A White1, T Vale, J H Camonis
1Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9039, USA.
Abstract:
Oncogenic Ras transforms cells through the activation of multiple downstream pathways mediated by separate effector molecules, one of which is Raf. Here we report the identification of a second ras-binding protein that can induce cellular transformation in parallel with activation of the Raf/mitogen-activated protein kinase cascade. The Ral guanine nucleotide dissociation stimulator (RalGDS) was isolated from a screen for Ras-binding proteins that specifically interact with a Ras effector-loop mutant, ras(12V,37G), that uncouples Ras from activation of Raf1. RalGDS, like ras(12V, 37G), cooperates synergistically with mutationally activated Raf to induce foci of growth and morphologically transformed NIH 3T3 cells. RalGDS does not significantly enhance MAP kinase activation by activated Raf, suggesting that the cooperativity in focus formation is due to a distinct pathway acting downstream of Ras and parallel to Raf.
Insights
Researchers discovered a new Ras-binding protein, Ral guanine nucleotide dissociation stimulator (RalGDS), that causes cell transformation independently of the Raf pathway. This finding reveals a parallel pathway for Ras-mediated cellular changes.
Area of Science:
- Cell biology
- Molecular oncology
- Signal transduction
Background:
- Oncogenic Ras proteins initiate cellular transformation via multiple downstream pathways.
- Raf is a known effector molecule mediating Ras-induced cellular changes.
- The existence of parallel Ras effector pathways remains an area of active investigation.
Purpose of the Study:
- To identify novel Ras-binding proteins involved in cellular transformation.
- To investigate pathways parallel to the Raf/mitogen-activated protein kinase (MAPK) cascade in Ras signaling.
- To characterize the function of Ral guanine nucleotide dissociation stimulator (RalGDS) in Ras-mediated cell transformation.
Main Methods:
- Screening for Ras-binding proteins using a Ras effector-loop mutant (ras(12V,37G)).
- Co-expression assays with activated Raf in NIH 3T3 cells to assess synergistic transformation.
- Analysis of MAP kinase activation levels in response to RalGDS and Raf co-expression.
Main Results:
- Identification of Ral guanine nucleotide dissociation stimulator (RalGDS) as a novel Ras-binding protein.
- RalGDS synergistically cooperated with activated Raf to induce significant cellular transformation (focus formation).
- RalGDS did not substantially enhance MAP kinase activation by activated Raf, indicating a distinct pathway.
Conclusions:
- RalGDS represents a second Ras effector pathway that contributes to cellular transformation independently of Raf.
- This discovery highlights the complexity of Ras signaling and identifies RalGDS as a key player in parallel oncogenic pathways.
- Further research into the RalGDS pathway could reveal new therapeutic targets for Ras-driven cancers.